Beijing-based clinical scientist Wang Yongjun just made medical history as the first Asian recipient of the William M. Feinberg Award at the 2025 International Stroke Conference! 🎉 The recognition comes after three decades of groundbreaking work that\u2019s literally rewriting how doctors treat strokes worldwide.
Dr. Wang\u2019s team at Beijing Tiantan Hospital cracked the code on extending stroke treatment windows from 4.5 hours to 24 hours using AI-powered imaging tech 🤖💡 \u2013 a game-changer giving 90% of patients access to life-saving thrombolytic therapy. Their aspirin-clopidogrel combo also slashed global stroke recurrence rates by nearly half!
\u201cThis is about teamwork at scale,\u201d Wang told conference attendees, revealing over 2,400 Chinese hospitals collaborate in his research network. 🌐 Their collective work has already helped one million Chinese patients avoid recurring strokes.
With stroke being China\u2019s leading cause of death, Wang\u2019s innovations are proving crucial. 💪 Fourteen of his team\u2019s 50+ national studies have become global treatment blueprints \u2013 including their work on minor strokes and late-window therapies currently in trials.
The three-day LA conference spotlighted Wang\u2019s achievements alongside 4,000 medical pros discussing next-gen stroke care. 🧠💼 Pro tip: Follow #ISC2025 for real-time updates on brain-saving tech!
